Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01350 (
gastrin
)
9,683
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Gastrin
influences polyamine synthesis in the enterocytes, which can lead to increased
DAO
activity. In diabetics with autonomic neuropathy (AN), a higher than normal
gastrin
concentration was found. However, in diabetics with enteropathy, a low level of plasma
DAO
activity was discovered. The purpose of this study was to investigate
gastrin
secretion and to evaluate
DAO
activity after i.v. injection of heparin in a group of diabetics with AN. Group I consisted of 12 diabetics with AN, group II 20 patients with diabetes without any complications and group III (the control group) 20 patients without diabetes. It was discovered that basal
gastrin
concentrations were significantly greater in group I (147 pg/ml +/- 76.5) that in groups II (78 pg/ml +/- 55.5)(p < 0.01) and III (61.5 pg/ml +/- 42.6)(p < 0.01).
DAO
activity was at its lowest in group I (247.1 pmol/min/ml +/- 104.8) and it was significantly different from group II (441 pmol/min/ml +/- 225.9)(p < 0.001) and III (540.7 pmol/min/ml +/- 171.1)(p < 0.001). There were no differences in the mean values of
gastrin
and
DAO
activity between group II and III. In group I low
DAO
activity was accompanied by a proportionally high concentration of the basal
gastrin
value (r = 0.567). In conclusion, in diabetics with AN, low postheparin plasma
DAO
activity was accompanied by a high basal
gastrin
value.
...
PMID:[Gastrinemia and heparin stimulated secretion of diamine oxidase on the course of diabetic autonomic neuropathy]. 929 89